Mylan Laboratories Ltd, the Operational Creditor, initiated Corporate Insolvency Resolution Process (CIRP) against Chiral Bio Sciences Ltd, the Corporate Debtor, under CP(IB) No.239/9/HDB/2017. Subsequently, an application IA(IBC)/194/2022 was filed by the Interim Resolution Professional (IRP) under Section 12A of the IBC, 2016, seeking permission to withdraw the CIRP. The application stated that the matter had been settled out of the tribunal. The tribunal reviewed the affidavit and was satisfied with the reasons for withdrawal. Consequently, the tribunal allowed the application, discharged the Corporate Debtor from the CIRP, and lifted the moratorium.

Mylan Laboratories Ltd, the Operational Creditor, initiated Corporate Insolvency Resolution Process (CIRP) against Chiral Bio Sciences Ltd, the Corporate Debtor, under CP(IB) No.239/9/HDB/2017. Subsequently, an application IA(IBC)/194/2022 was filed by the Interim Resolution Professional (IRP) under Section 12A of the IBC, 2016, seeking permission to withdraw the CIRP. The application stated that the matter had been settled out of the tribunal. The tribunal reviewed the affidavit and was satisfied with the reasons for withdrawal. Consequently, the tribunal allowed the application, discharged the Corporate Debtor from the CIRP, and lifted the moratorium.